The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karras, J. G.
Right arrow Articles by Rothstein, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karras, J. G.
Right arrow Articles by Rothstein, T. L.

The Journal of Immunology, Vol 157, Issue 6 2299-2309, Copyright © 1996 by American Association of Immunologists


ARTICLES

Delayed tyrosine phosphorylation and nuclear expression of STAT1 following antigen receptor stimulation of B lymphocytes

JG Karras, L Huo, Z Wang, DA Frank, JM Zimmet and TL Rothstein
Department of Medicine, Boston University Medical Center, MA 02118, USA.

The regulation of the STAT1 alpha transcription factor was assessed during B cell activation induced by cross-linking the surface IgM Ag receptor. Surface Ig ligation or pharmacologic stimulation with PMA and ionomycin resulted in the delayed (2-3 h after stimulation) nuclear appearance of tyrosine-phosphorylated STAT1 alpha, in contrast to the rapid induction that follows cytokine treatment. Nuclear expression of phosphorylated STAT1 alpha was abrogated by co-incubation of anti-Ig- treated B cells with the protein synthesis inhibitor cycloheximide (CHX), with the protein kinase inhibitor H-7, or with the immunosuppressive drug rapamycin. Tyrosine-phosphorylated STAT1 alpha was found to be recruited to the STAT binding site of the IFN regulatory factor-1 (IRF-1) gene promoter only after 2 to 3 h, and this association was also inhibitable by CHX and rapamycin. The arrival of STAT1 alpha coincided with attenuation of anti-Ig-induced STAT-binding activity specific for the IRF-1 promoter site, and both rapamycin and CHX treatment counteracted the loss of this activity. Furthermore, basal transcription of the endogenous IRF-1 gene was decreased as a result of anti-Ig treatment, and this effect of anti-Ig was blocked by co-incubation with rapamycin. Thus, STAT1 alpha plays a dynamic role in the composition of IRF-1 promoter-specific DNA binding complexes stimulated by B cell Ag receptor ligation, and nuclear expression of phosphorylated STAT1 alpha is regulated in a unique fashion by Ag receptor engagement. In addition, surface Ig cross-linking imparts negative regulatory control of IRF-1 gene expression, possibly through activation of STAT1 alpha.


This article has been cited by other articles:


Home page
J. Immunol.Home page
M. F. Quiroga, G. J. Martinez, V. Pasquinelli, M. A. Costas, M. M. Bracco, A. Malbran, L. M. Olivares, P. A. Sieling, and V. E. Garcia
Activation of Signaling Lymphocytic Activation Molecule Triggers a Signaling Cascade That Enhances Th1 Responses in Human Intracellular Infection
J. Immunol., September 15, 2004; 173(6): 4120 - 4129.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Su, R. C. Rickert, and M. David
Rapid STAT Phosphorylation via the B Cell Receptor. MODULATORY ROLE OF CD19
J. Biol. Chem., November 5, 1999; 274(45): 31770 - 31774.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Delgado and D. Ganea
Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Interleukin-12 Transcription by Regulating Nuclear Factor kappa B and Ets Activation
J. Biol. Chem., November 5, 1999; 274(45): 31930 - 31940.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. Dumler, A. Kopmann, A. Weis, O. A. Mayboroda, K. Wagner, D. C. Gulba, and H. Haller
Urokinase Activates the Jak/Stat Signal Transduction Pathway in Human Vascular Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., February 1, 1999; 19(2): 290 - 297.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Berland and H. H. Wortis
An NFAT-Dependent Enhancer Is Necessary for Anti-IgM-Mediated Induction of Murine CD5 Expression in Primary Splenic B Cells
J. Immunol., July 1, 1998; 161(1): 277 - 285.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Mey and J.-P. Revillard
Mitogenic Response of Murine B Lymphocytes to Salmonella typhimurium Lipopolysaccharide Requires Protein Kinase C-Dependent Late Tyrosine Phosphorylations
Infect. Immun., June 1, 1998; 66(6): 2547 - 2552.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
J. G. Karras, Z. Wang, L. Huo, R. G. Howard, D. A. Frank, and T. L. Rothstein
Signal Transducer and Activator of Transcription-3 (STAT3) Is Constitutively Activated in Normal, Self-renewing B-1 Cells but Only Inducibly Expressed in Conventional B Lymphocytes
J. Exp. Med., March 17, 1997; 185(6): 1035 - 1042.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.